Stay updated with breaking news from 87837710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from $104.00 to $65.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 17.31% from the stock’s […]
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Equities researchers at Leerink Partnrs lowered their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.40 per share for the quarter, down from their prior estimate […]
Bio-Techne Co. (NASDAQ:TECH – Free Report) – Investment analysts at KeyCorp increased their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. KeyCorp analyst P. Knight now expects that the biotechnology company will post earnings per share of $0.43 for the quarter, up from their previous estimate […]
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Bio-Techne from a b- rating to a c+ rating in a research report […]
Rowland & Co. Investment Counsel ADV decreased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the quarter. Rowland & Co. […]